Background: Coronavirus disease 2019 (COVID-19) has been associated with many neurological complications affecting the central nervous system. Purpose: Our aim was to describe a case of COVID-19 associated with a probable variant of acute necrotizing encephalopathy (ANE). Results: A 60-year-old man who presented with a 3-day history of dyspnea, fever, and cough tested positive for severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2). Five days following his admission, the patient was intubated secondary to respiratory failure. Following his extubation 16 days later, he was found to have a left-sided weakness. Magnetic resonance imaging (MRI) of the brain showed hemorrhagic rim-enhancing lesions involving the right thalamus, left hippocampus, and left parahippocampal gyrus. These lesions showed decreased relative cerebral blood flow on MR perfusion and restricted on diffusion-weighted imaging. These neuroimaging findings were consistent with ANE. The left-sided weakness gradually improved over the subsequent weeks. Conclusions: We concluded that COVID-19 can be associated with ANE, a condition believed to be the result of an immune-mediated process with activation of the innate immune system. Future studies must address whether biological drugs targeting the pro-inflammatory cytokines could prevent the development of this condition.
MizuguchiMAbeJMikkaichiK, et al.Acute necrotising encephalopathy of childhood: A new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatr. 1995;58:555-561.
2.
WongASimonEZimmermanR, et al.Acute necrotizing encephalopathy of childhood: Correlation of MR findings and clinical outcome. American journal of neuroradiology. 2006;27:1919-1923.
3.
GrzonkaPScholzMCDe MarchisGM, et al.Acute Hemorrhagic Leukoencephalitis: A Case and Systematic Review of the Literature. Front Neurol2020;11:899.
4.
ItoYIchiyamaTKimuraH, et al.Detection of influenza virus RNA by reverse transcription‐PCR and proinflammatory cytokines in influenza‐virus‐associated encephalopathy. J Med Virol. 1999;58:420-425.
5.
YoshikawaHWatanabeTAbeT, et al.Clinical diversity in acute necrotizing encephalopathy. J Child Neurol. 1999;14:249-255.
DixonLVarleyJGontsarovaA, et al.COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020;7:e789. 2020/05/28. doi:10.1212/NXI.0000000000000789.
8.
DelamarreLGollionCGrouteauG, et al.COVID-19–associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network. J Neurol Neurosurg Psychiatr. 2020;91:1004-1006.
9.
MastroyianniSDGionnisDVoudrisK, et al.Acute necrotizing encephalopathy of childhood in non-Asian patients: Report of three cases and literature review. J Child Neurol. 2006;21:872-879.
10.
OffiahCHallE. Acute necrotizing encephalopathy associated with novel influenza H1N1 (pdm09) infection: MRI and correlation with brain necropsy. J Pediatr Neuroradiol. 2013;2:319-324.
11.
GonagleaDSharifaKO’RegandA. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev2020.
12.
QiXKeithKAHuangJH. COVID-19 and stroke: A review. Brain hemorrhages2020;2:76-83.
